137 related articles for article (PubMed ID: 36813114)
1. Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology.
Liposits G; Arora SP; Battisti NML; Soto-Perez-de-Celis E; Loh KP; Williams GR
Ann Oncol; 2023 Jun; 34(6):555-556. PubMed ID: 36813114
[No Abstract] [Full Text] [Related]
2. TOPAZ-1: a new standard of care for advanced biliary tract cancers?
Ebia MI; Sankar K; Osipov A; Hendifar AE; Gong J
Immunotherapy; 2023 May; 15(7):473-476. PubMed ID: 36950948
[No Abstract] [Full Text] [Related]
3. Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?
Rizzo A; Cusmai A; Palmiotti G
Expert Rev Gastroenterol Hepatol; 2022 Mar; 16(3):201-203. PubMed ID: 35220859
[No Abstract] [Full Text] [Related]
4. Second-line FOLFOX chemotherapy for advanced biliary tract cancer.
Pramanik R; Sharma A; Kumar A
Lancet Oncol; 2021 Jul; 22(7):e287. PubMed ID: 34197750
[No Abstract] [Full Text] [Related]
5. Second-line FOLFOX chemotherapy for advanced biliary tract cancer.
Foo T; Kichenadasse G; Roy A; Karapetis CS
Lancet Oncol; 2021 Jul; 22(7):e286. PubMed ID: 34197749
[No Abstract] [Full Text] [Related]
6. Second-line FOLFOX chemotherapy for advanced biliary tract cancer.
Brandi G; Frega G; Rizzo A
Lancet Oncol; 2021 Jul; 22(7):e285. PubMed ID: 34197748
[No Abstract] [Full Text] [Related]
7. Second-line FOLFOX chemotherapy for advanced biliary tract cancer.
Wei F
Lancet Oncol; 2021 Jul; 22(7):e284. PubMed ID: 34197747
[No Abstract] [Full Text] [Related]
8. Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Lamarca A; Palmer DH; Wasan HS; Ross PJ; Ma YT; Arora A; Falk S; Gillmore R; Wadsley J; Patel K; Anthoney A; Maraveyas A; Iveson T; Waters JS; Hobbs C; Barber S; Ryder WD; Ramage J; Davies LM; Bridgewater JA; Valle JW;
Lancet Oncol; 2021 Jul; 22(7):e288-e289. PubMed ID: 34197751
[No Abstract] [Full Text] [Related]
9. Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers.
Mathers B; Abadi S; Davies JM; McIntyre C; Ho C
J Oncol Pharm Pract; 2023 Sep; 29(6):1381-1386. PubMed ID: 36320173
[TBL] [Abstract][Full Text] [Related]
10. A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin.
He S; Shen J; Sun X; Liu L; Dong J
J Chemother; 2014 Aug; 26(4):243-7. PubMed ID: 24070164
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14).
Lee CK; Chon HJ; Cheon J; Lee MA; Im HS; Jang JS; Kim MH; Park S; Kang B; Hong M; Kim JW; Park HS; Kang MJ; Park YN; Choi HJ
Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):56-65. PubMed ID: 36328033
[TBL] [Abstract][Full Text] [Related]
12. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.
Kameda R; Ando T; Kobayashi S; Ueno M; Ohkawa S
Jpn J Clin Oncol; 2013 Jun; 43(6):636-40. PubMed ID: 23619988
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
Moehler M; Maderer A; Schimanski C; Kanzler S; Denzer U; Kolligs FT; Ebert MP; Distelrath A; Geissler M; Trojan J; Schütz M; Berie L; Sauvigny C; Lammert F; Lohse A; Dollinger MM; Lindig U; Duerr EM; Lubomierski N; Zimmermann S; Wachtlin D; Kaiser AK; Schadmand-Fischer S; Galle PR; Woerns M;
Eur J Cancer; 2014 Dec; 50(18):3125-35. PubMed ID: 25446376
[TBL] [Abstract][Full Text] [Related]
16. Current status of chemotherapy for the treatment of advanced biliary tract cancer.
Sasaki T; Isayama H; Nakai Y; Koike K
Korean J Intern Med; 2013 Sep; 28(5):515-24. PubMed ID: 24009445
[TBL] [Abstract][Full Text] [Related]
17. FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer.
Novarino AM; Satolli MA; Chiappino I; Giacobino A; Napoletano R; Ceccarelli M; Ciccone G; Schena M; Bertetto O; Ciuffreda L
Am J Clin Oncol; 2013 Oct; 36(5):466-71. PubMed ID: 22781390
[TBL] [Abstract][Full Text] [Related]
18. Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective.
Tam VC; Ramjeesingh R; Burkes R; Yoshida EM; Doucette S; Lim HJ
Curr Oncol; 2022 Sep; 29(10):7072-7085. PubMed ID: 36290832
[TBL] [Abstract][Full Text] [Related]
19. Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers: A Multicenter Retrospective Population-based Cohort Study.
Zaidi A; Chandna N; Narasimhan G; Moser M; Haider K; Chalchal H; Shaw J; Ahmed S
Am J Clin Oncol; 2021 Mar; 44(3):93-98. PubMed ID: 33350678
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study.
Ueno M; Ikeda M; Morizane C; Kobayashi S; Ohno I; Kondo S; Okano N; Kimura K; Asada S; Namba Y; Okusaka T; Furuse J
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):611-621. PubMed ID: 31109808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
